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Summary
Aging is associated with marked deficiency in circulating IGF-1,
which has been shown to contribute to age-related cognitive
decline. Impairment of moment-to-moment adjustment of cere-
bral blood flow (CBF) via neurovascular coupling is thought to
play a critical role in the genesis of age-related cognitive
impairment. To establish the link between IGF-1 deficiency and
cerebromicrovascular impairment, neurovascular coupling mech-
anisms were studied in a novel mouse model of IGF-1 deficiency
(Igf1f/f-TBG-Cre-AAV8) and accelerated vascular aging. We found
that IGF-1-deficient mice exhibit neurovascular uncoupling and
show a deficit in hippocampal-dependent spatial memory test,
mimicking the aging phenotype. IGF-1 deficiency significantly
impaired cerebromicrovascular endothelial function decreasing
NO mediation of neurovascular coupling. IGF-1 deficiency also
impaired glutamate-mediated CBF responses, likely due to dys-
regulation of astrocytic expression of metabotropic glutamate
receptors and impairing mediation of CBF responses by eicosa-
noid gliotransmitters. Collectively, we demonstrate that IGF-1
deficiency promotes cerebromicrovascular dysfunction and neu-
rovascular uncoupling mimicking the aging phenotype, which are
likely to contribute to cognitive impairment.
Key words: arachidonic acid metabolites; astrocyte; endo-
thelial dysfunction; functional hyperemia; Insulin-like growth
factor-1; neurovascular uncoupling; nitric oxide; somatome-
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Introduction
Vascular cognitive impairment (VCI) in the aging population poses a
serious challenge to developed countries around the world. With the
expansion of the aging population, understanding potentially reversible
and preventable vascular contributions to age-related cognitive impair-
ment and dementia is of critical importance.
There is increasing evidence that in addition to pathologies affecting
the larger cerebral arteries (e.g. atherosclerosis), pathophysiological
alterations of the cerebral microcirculation have a critical role in age-
related decline in brain function (Gorelick et al., 2011). Among them,
age-related functional changes in the neurovascular unit that have the
potential to impair local regulation of cerebral blood flow are of great
importance (Iadecola et al., 2009). The energy requirements of neurons
are high. Yet, the brain contains little energy reserves and, during
neuronal activation, there is a need for rapid increases in oxygen and
glucose delivery. This is ensured by neurovascular coupling, a vital feed-
forward control mechanism involving neuronal signaling via neurotrans-
mitters, which adjusts local cerebral blood flow (CBF) to the energy
requirements of activated neurons. The resulting functional hyperemia is
responsible for maintenance of an optimal local microenvironment in the
cerebral tissue by increasing delivery of oxygen and glucose and removal
of potentially deleterious by-products of cerebral metabolism. Aging is
associated with significant impairment of functional hyperemia (termed
‘neurovascular uncoupling’), and the ensuing disruption of the cerebral
microenvironment likely contributes to impairment of higher cerebral
function in elderly patients and aged laboratory animals (Zaletel et al.,
2005; Park et al., 2007; Topcuoglu et al., 2009; Fabiani et al., 2013;
Sorond et al., 2013; Stefanova et al., 2013; Toth et al., 2014a). Yet, the
specific age-related mechanisms responsible for neurovascular uncou-
pling are not yet understood.
There is increasing evidence suggesting that neuroendocrine mech-
anisms have an important role in age-related vascular alterations
(Ungvari & Csiszar, 2012; Sonntag et al., 2013). In particular, the age-
related decline in circulating insulin-like growth factor-1 (IGF-1) levels
appears to contribute significantly to age-related microvascular changes
and cognitive decline (reviewed recently in Sonntag et al. (2013)).
Neurovascular coupling depends on an intact functional network of
neurons, vascular endothelial cells, and astrocytes (Attwell et al., 2010;
Chen et al., 2014). Although these cell types abundantly express IGF-1
receptors and are known targets of IGF-1 (Sonntag et al., 2013), the role
of IGF-1 in the regulation of functional hyperemia in response to
neuronal activation is not well understood. The cellular mechanisms
underlying neurovascular coupling include endothelial production of
nitric oxide (NO) (Ma et al., 1996; Stobart et al., 2013; Chen et al.,
2014) as well as astrocytic production of vasodilator metabolites of
arachidonic acid, including epoxygenase-derived epoxyeicosatrienoic
acids (EETs) and cyclooxygenase-derived prostaglandins (Peng et al.,
2002; Zonta et al., 2003; Takano et al., 2006). Importantly, previous
studies demonstrate that IGF-1 deficiency leads to endothelial dysfunc-
tion and impaired bioavailability of NO in the peripheral circulation
(reviewed in Ungvari & Csiszar (2012)). IGF-1 was also shown to regulate
cellular arachidonic acid metabolism (Tahara et al., 1991; Berenbaum
et al., 1994; Damke et al., 1994; Sharma et al., 1997). Despite these
advances, the effects of IGF-1 deficiency on the cerebral microcirculation
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and mediation of neurovascular coupling by NO, EETs, and eicosanoid
gliotransmitters remain elusive.
This study was designed to test the hypotheses that IGF-1 regulates
synthesis/release of NO and vasodilator eicosanoid gliotransmitters in the
cerebral microcirculation and that low circulating IGF-1 levels impair
neurovascular coupling in the brain, mimicking the aging phenotype. To
test our hypotheses, we used a novel mouse model of adult-onset,
isolated endocrine IGF-1 deficiency induced by adeno-associated viral
knockdown of IGF-1 specifically in the liver of postpubertal mice using
Cre-lox technology (Igf1f/f + TBG-Cre-AAV8) (Toth et al., 2014b). Neu-
rovascular coupling, synthesis of eicosanoid gliotransmitters, astrocytic
gene expression, and cerebromicrovascular endothelial function were
tested. To substantiate our findings, behavioral studies known to be
sensitive for neurovascular uncoupling (tests indicative for learning and
memory) were conducted.
Results
IGF-1 deficiency impairs neurovascular coupling and
cognitive function
Figure 1A shows that mice receiving TBG-Cre-AAV8 had significantly
lower serum IGF-1 levels compared with control mice receiving TBG-
eGFP-AAV8. Both groups had similar serum IGF-1 levels prior to the
administration of liver-targeted viruses (data not shown). Consistent with






Fig. 1 IGF-1 deficiency impairs neurovascular coupling and cognitive function. Panel A shows that adeno-associated viral knockdown of hepatic Igf1 (Igf1f/f + TBG-Cre-
AAV8) decreases significantly the level of circulating IGF-1 compared to control animals (Igf1f/f + TBG-eGFP-AAV8) (*P < 0.05 vs. control). (B) Representative traces of
cerebral blood flow (CBF) measured with a laser Doppler probe above the whisker barrel cortex during contralateral whisker stimulation (5 Hz) in control and IGF-1-deficient
mice. 1 AU corresponds to ~5% increase in CBF from baseline. Right panel depicts the summary data of the CBF responses (DAUC as % of baseline; n = 12, *P < 0.001 vs.
control). (C–D) Spontaneous and evoked neural activity is not altered in IGF-1-deficient mice. (C) The amplitude and frequency distribution of neocortical electrical activity are
nearly identical in control and IGF-1-deficient mice (inlet shows original recording of electrocorticograms, n = 6, P = 0.4). (D) The somatosensory evoked potential (SEP)
responses in the somatosensory cortex evoked by contralateral whisker pad stimulation are comparable in control and IGF-1-deficient mice. The arrow indicates the
application of the stimulus. The amplitude of the negative wave of the field potentials (N1) does not differ between control and IGF-1-deficient mice (n = 6, P = 0.6). (E–F)
Spatial memory testing of mice in Y-maze. The IGF-1-deficient animals (Igf1f/f + TBG-Cre-AAV8) exhibited impaired spatial memory as shown by the decreased number of
entries in novel arm (E; * P = 0.001 vs. control) and shorter exploratory time spent in novel arm of the Y-maze during retrieval trial (F; and P = 0.01 vs. control). Data are
mean  S.E.M., n = 20 in each group.
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IGF-1 levels in the brain (Nishijima et al., 2010), we found that mice
receiving TBG-Cre-AAV8 also had significantly lower tissue IGF-1 levels in
the cerebral cortex comparedwith controlmice receiving TBG-eGFP-AAV8
(4.8  1.7 and 11.4  2.4 pg mg1 of tissue, respectively; P = 0.03).
Changes in CBF in the whisker barrel cortex in response to
contralateral whisker stimulation were significantly attenuated in IGF-
1-deficient mice (Fig. 1B), indicating that IGF-1 deficiency leads to
neurovascular uncoupling, mimicking the aging phenotype (Toth et al.,
2014a). IGF-1 deficiency could reduce functional hyperemia by impairing
neural activity evoked by whisker stimulation. To examine this possibility,
we recorded spontaneous and evoked neural activity in control and IGF-
1-deficient mice. We found that the amplitude and frequency distribu-
tion of the electrocorticogram and the amplitude of the somatosensory
field potentials produced by the activation of the whisker pad do not
differ between control and IGF-1-deficient mice (Fig. 1C–D). Therefore,
IGF-1 deficiency is unlikely to contribute to impaired functional hyper-
emia by modulating the neural activity evoked by whisker stimulation.
Our recent studies demonstrate that selective experimental disruption
of neurovascular coupling responses is associated with significant
impairment of cognitive function, recapitulating neurological symptoms
and signs observed in brain aging (Tarantini, Ungvari and Toth,
manuscript in preparation 2015). In this study, for the hippocampal-
dependent spatial memory test, the control mice entered the novel arm
more often than the IGF-1-deficient mice following the intertrial interval
(Fig. 1C). The control mice also spent significantly more time in the novel
arm than the previously visited arms, whereas the IGF-1-deficient mice
spent significantly less time in the novel arm (Fig. 1D), indicating that
neurovascular uncoupling induced by IGF-1 deficiency is also associated
with impaired spatial working memory and novelty-seeking behavior.
Previous studies using the Morris water maze (Trejo et al., 2007) and the
Barnes maze (Sonntag and Csiszar, unpublished data, 2012) also yielded
similar results, showing that IGF-1-deficient mice exhibit impaired spatial
working memory. Learning and/or memory deficits were also observed in
GH/IGF-1-deficient Lewis dwarf rats (Nieves-Martinez et al., 2010),
spontaneously dwarf SD rats (Li et al., 2011), and in Ames dwarf mice in
some (Derenne et al., 2011), but not all (Sharma et al., 2010), studies.
IGF-1 deficiency impairs cerebromicrovascular endothelial
function: role in neurovascular uncoupling
We found that in control animals, the administration of the NO synthase
inhibitor L-NAME significantly decreased CBF responses in the barrel
cortex elicited by contralateral whisker stimulation (Fig. 2A). In IGF-1-
deficient animals, the effect of L-NAME was blunted (Fig. 2A), suggest-
ing that IGF-1 deficiency impairs NO mediation, which contributes to
neurovascular uncoupling. Topical application of the endothelium-
dependent vasodilator agent acetylcholine (ACh; 105 mol L1) resulted
in a significant increase in CBF in the barrel cortex of control mice
(Fig. 2B). ACh-induced CBF responses were significantly attenuated in
IGF-1-deficient mice (Fig. 2B), supporting the concept that IGF-1
deficiency impairs cerebromicrovascular endothelial function, mimicking
the aging phenotype (Toth et al., 2014a). Previously, it has been found
that in models of vascular aging in the periphery, IGF-1 decreases
vascular oxidative stress and improves endothelial function (Ungvari &
Csiszar, 2012), whereas it does not significantly affect endothelium-
independent vasodilation elicited by NO donors (Bailey-Downs et al.,
2012). We found that in IGF-1-deficient mice, 3-nitrotyrosine content in
the cerebral cortex is significantly elevated (Fig. 2C) consistent with
increased oxidative/nitrosative stress in the brain, which mimics the




Fig. 2 IGF-1 deficiency impairs
cerebromicrovascular endothelial function:
role in neurovascular uncoupling. (A)
L-NAME-sensitive, NO-mediated portion of
the CBF response (calculated based on the
percentage decline in CBF in the presence
of L-NAME) measured above the barrel field
of the primary somatosensory cortex in
response to whisker stimulation in control
and IGF-1-deficient (Igf1f/f + TBG-Cre-
AAV8) mice (n = 6, * P < 0.05 vs. control; #
P < 0.05 vs. control w/o drug; &P < 0.05 vs.
Igf1f/f + TBG-Cre-AAV8 w/o drug). (B) CBF
responses elicited by topical administration
of acetylcholine to the barrel field of control
and IGF-1-deficient mice (n = 6, *P < 0.05
vs. control). (C) Protein 3-nitrotyrosine
content, a biomarker of increased ONOO-
formation, in cortical tissue of IGF-
1-deficient and control mice (n = 5,
*P < 0.05 vs. control). (D) qPCR data
showing mRNA expression of the
endothelial nitric oxide synthase (Nos3) and
the NADPH oxidase subunits Nox1, Nox2,
and Nox4 in cortical samples of
IGF-1-deficient and control mice. Data are
mean  S.E.M. (n = 5, *P < 0.05 vs.
control).
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with decreased expression of Nos3 (Fig. 2D). In IGF-1-deficient mice, the
expression of Nox1 and Nox2 subunits of the NADPH oxidase tended to
increase; however, the differences did not reach statistical significance
(Fig. 2D).
IGF-1 deficiency impairs glutamate-mediated CBF responses:
role in neurovascular uncoupling
Astrocytes were suggested to sense neuronal-derived glutamate through
metabotropic glutamate receptors (mGluR) and NMDA receptors,
leading to increased production of vasodilator gliotransmitters that
contribute to neurovascular coupling (Petzold & Murthy, 2011). In
support of this concept, we found that in control mice, the metabotropic
Glu receptor blocker MPEP and NMDA receptor blocker D-APV
significantly decreased CBF responses in the barrel cortex elicited by
contralateral whisker stimulation (Fig. 3A). In IGF-1-deficient animals,
the effect of MPEP plus D-APV was significantly decreased (Fig. 3A),
suggesting that IGF-1 deficiency impairs glutamate-mediated neurovas-
cular coupling. Further support for this concept is provided by the





Fig. 3 IGF-1 deficiency impairs glutamate-
mediated CBF responses: role in
neurovascular uncoupling. (A) Effects of
treatment with antagonists of
metabotropic glutamate receptors (MPEP,
5 9 105 mol L1) and NMDA receptors
(N-methyl-D-aspartate, D-APV,
5 9 105 mol L1) on cerebral blood flow
(CBF) responses measured above the barrel
field of the primary somatosensory cortex in
response to whisker stimulation in control
and IGF-1-deficient mice (Igf1f/f + TBG-Cre-
AAV8). The inlet shows the glutamate-
mediated part of the neurovascular
response in each group (n = 6 in each
group, *P < 0.05 vs. control; #P < 0.05 vs.
Igf1f/f + TBG-Cre-AAV8). (B) CBF responses
measured above the barrel field of the
primary somatosensory cortex elicited by
topical administration of L-glutamate
(500 lmol L1) in control and IGF-1-
deficient mice (n = 6 in each group,
*P < 0.05 vs. control). Panel C Original
recordings of changes in extracellular
glutamate in response to whisker
stimulation (5 Hz, 2 min) measured by
amperometry using a glutamate biosensor
inserted into the barrel cortex of mice (see
Methods for details). ‘Null sensor’ indicates
a biosensor constructed the same way as
the glutamate sensors but without any
enzymes for biosensing. Summary data are
shown in Panel D. No significant differences
(P = 0.4) were observed between cortical
glutamate signals induced by whisker
stimulation in control (n = 5) and IGF-1-
deficient mice (Igf1f/f + TBG-Cre-AAV8,
n = 7). (E) qPCR data showing mRNA
expression of NMDA receptors (Grin1,
Grin2A, Grin2B), metabotropic glutamate
receptors (Grm1, Grm2, Grm3, Grm4,
Grm5), and glutamate transporters (Slc1a1,
Slc1a2) on astrocytes isolated from control
and IGF-1-deficient animals (n = 5).
*P < 0.05 vs. control. Data are
mean  S.E.M. for every panel of the
figure.
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were also significantly impaired (Fig. 3B). IGF-1 deficiency did not alter
glutamate release induced by neuronal activation (Fig. 3C–D), whereas it
dysregulated the astrocytic expression of metabotropic glutamate
receptors (Grm2, Grm4, Grm5) and NMDA receptors (Grin1 and Grin2;
Fig. 3E).
IGF-1 deficiency impairs mediation of CBF responses by
eicosanoid gliotransmitters: role in neurovascular uncoupling
Upon activation by neuronal-derived glutamate, astrocytes were shown
to convert arachidonic acid by cyclooxygenases to vasodilator prosta-
glandins and by P450 epoxygenase to vasodilator EETs (Petzold &
Murthy, 2011). Consistent with this concept, we found that in control
animals, the administration of the cyclooxygenase inhibitor indometh-
acin (Fig. 4A) and P450 epoxygenase inhibitor MS-PPOH (Fig. 4B)
significantly decreased CBF responses in the barrel cortex elicited by
contralateral whisker stimulation. In IGF-1-deficient animals, the effects
of indomethacin (Fig. 4A) and MS-PPOH (Fig. 4B) were significantly
decreased, suggesting that IGF-1 deficiency impairs the mediation of
neurovascular coupling by prostaglandins and EETs. The astrocyte-
derived vasoconstrictor eicosanoid 20-HETE can also negatively impact
neurovascular coupling. Using the cytochrome P450 x-hydroxylase
inhibitor HET0016, we found that IGF-1 deficiency tended to increase
the HET0016-sensitive component of the CBF response, indicating that a
20-HETE-dependent constrictor response is present in IGF-1-deficient
mice (Fig. 4C). LC/MS/MS measurements demonstrated that IGF-1
deficiency resulted in a diminished cerebral production of the potent
vasodilator 14,15-EET (which is the most prevalent among the four EET
regioisomers in the murine brain) in response to glutamate stimulation of
brain slices (Fig. 4D). IGF-1 deficiency also tended to increase the
cerebral production of 20-HETE (Fig. 4E). Among the investigated
factors known to be involved in the synthesis of eicosanoid gliotrans-
mitters, the expression of Cyp2c55 decreased, whereas the expression of
the 20-HETE-producing x-hydroxylase Cyp4a10 increased in IGF-1-
deficient mice (Fig. 4F).
Discussion
Circulating IGF-1 concentrations decrease significantly with age, due to
decreases in GH levels, both in humans and in laboratory animals
(Sonntag et al., 2005, 2013). There is substantial evidence that
circulating IGF-1 is an important vascular protective factor and that the
age-related decline in IGF-1 levels contributes to vascular aging,
promoting atherogenesis and development of cardiovascular disease
and stroke (reviewed recently in Ungvari & Csiszar (2012) and Sonntag
et al. (2013)). Here, we show for the first time that circulating IGF-1
deficiency also leads to profound neurovascular dysregulation, charac-
terized by impaired CBF responses induced by synaptic activity (Fig. 1),
which mimics the cerebromicrovascular aging phenotype (Toth et al.,
2014a). Impairment of a key homeostatic mechanism matching energy
supply with the needs of active neuronal tissue is predicted to have
deleterious effects on brain function. Indeed, there is strong evidence
that in elderly patients, impaired neurovascular coupling (Zaletel et al.,
2005; Topcuoglu et al., 2009; Stefanova et al., 2013) associates with
decline in higher cortical functions including cognition. Importantly,
neurovascular uncoupling in IGF-1-deficient mice also associates with
impaired cognitive function (Fig. 1), mimicking the aging phenotype
(Csiszar et al., 2013).
Although IGF-1 deficiency may impact multiple aspects of neuronal
function (Sonntag et al., 2013), our recent studies strongly suggest that
a direct mechanistic link exists between neurovascular uncoupling and
cognitive decline. Accordingly, recently we found that experimentally
induced acute neurovascular uncoupling in mice, in the absence of
alterations in synaptic function, leads to impaired performance in tests
relevant for hippocampal- and cortical-dependent tasks of learning and
memory (Tarantini, Ungvari and Toth, manuscript in preparation 2015).
In humans, IGF-1 deficiency is associated with progressive cognitive
dysfunction that can be reversed by increasing circulating IGF-1 levels
(reviewed in Sonntag et al. (2013)). Rodents have a similar decrease in
circulating IGF-1 levels with age and treatment of aged F344xBN rats
with IGF-1 was shown to improve cognitive function (reviewed in
Sonntag et al. (2013)). Thus, further studies are warranted to determine
whether in the aforementioned models treatment with IGF-1 rescues
neurovascular coupling and to establish a causal link between IGF-1-
dependent changes in functional hyperemia and cognitive function. In
addition to exerting protective effects on neurovascular coupling
responses, IGF-1 may also protect brain function by additional mecha-
nisms, including exerting trophic effects on central glutamatergic
synapses (Trejo et al., 2007) and/or preventing blood brain barrier
disruption and neuroinflammation (Toth et al., 2014b).
The effects of IGF-1 deficiency on the cellular mechanisms involved in
neurovascular coupling are likely multifaceted. Microvascular endothelial
cells are directly exposed to circulating IGF-1 and are known to
abundantly express IGF-1 receptors (Ungvari & Csiszar, 2012). Impor-
tantly, there is growing experimental evidence that NO production by
cerebromicrovascular endothelial cells has an important role in functional
hyperemia (Girouard et al., 2007; Longden & Nelson, 2011; Stobart
et al., 2013). This concept is supported by our observation that inhibition
of NO synthesis significantly reduces neurovascular coupling in control
animals (Fig. 2). It is significant that impaired endothelial NO production
was shown to contribute to age-related neurovascular uncoupling in
mice (Park et al., 2007; Toth et al., 2014a). The findings that in IGF-1-
deficient mice (Fig. 2), the L-NAME-sensitive, NO-mediated portion of
the neurovascular coupling response was decreased suggest that
cerebromicrovascular endothelial dysfunction also contributes to neuro-
vascular uncoupling in IGF-1 deficiency (Park et al., 2007), mimicking the
aging phenotype (Park et al., 2007; Toth et al., 2014a). The mechanisms
by which IGF-1 deficiency impairs cerebromicrovascular endothelial
function likely involve an increased breakdown of NO by elevated levels
of ROS. Several lines of evidence support this concept. First, IGF-1-
deficient mice, similar to aged mice (Park et al., 2007; Toth et al.,
2014a), exhibit increased production of ROS (Csiszar et al., 2008).
Second, the treatment of primary endothelial cells with IGF-1 signifi-
cantly attenuates cellular ROS generation (Csiszar et al., 2008). Third, in
the microcirculation, endothelium-derived NO was shown to react with
increased O2
. forming ONOO, thus decreasing the bioavailability of
NO (Csiszar et al., 2002; Pacher et al., 2007). The brains of IGF-1-
deficient mice, similar to aged mice (Toth et al., 2014a), exhibit an
increased 3-nitrotyrosine content (Fig. 2), a biomarker of increased
ONOO formation, indicating that increased scavenging of vasodilator
NO contributes to impaired endothelial mediation of cerebromicrovas-
cular dilation in IGF-1 deficiency. Previous studies suggest that increased
activity/expression of NADPH oxidases and increased ROS production by
mitochondrial sources contribute significantly to aging-induced micro-
vascular oxidative stress (Park et al., 2007; Ungvari & Csiszar, 2012; Toth
et al., 2014a). Accordingly, the findings that treatment with a pharma-
cological inhibitor of cellular ROS production is able to improve
functional hyperemia provide direct evidence for the role of increased
oxidative stress in neurovascular uncoupling both in IGF-1-deficient mice
and in aged mice (Toth et al., 2014a). Importantly, impaired endothelial
IGF-1 deficiency and neurovascular uncoupling, P. Toth et al.1038





Fig. 4 IGF-1 deficiency impairs mediation of CBF responses by eicosanoid gliotransmitters: role in neurovascular uncoupling. (A) Indomethacin-sensitive, prostaglandin-
mediated portion of the CBF response (calculated based on the percentage decline in CBF in the presence of INDO) measured above the barrel field of the primary
somatosensory cortex in response to whisker stimulation in control and IGF-1-deficient (Igf1f/f + TBG-Cre-AAV8) mice (n = 6 in each group, *P < 0.05 vs. control; #P < 0.05
vs. control w/o INDO; &P < 0.05 vs. Igf1f/f + TBG-Cre-AAV8 w/o INDO). (B) MS-PPOH-sensitive, EET-mediated portion of the CBF response (calculated based on the
percentage decline in CBF in the presence of MS-PPOH) measured above the barrel field of the primary somatosensory cortex in response to whisker stimulation in control
and IGF-1-deficient (Igf1f/f + TBG-Cre-AAV8) mice (n = 6 in each group, *P < 0.05 vs. control; #P < 0.05 vs. control w/o MS-PPOH; &P < 0.05 vs. Igf1f/f + TBG-Cre-AAV8 w/
o MS-PPOH). (C) HET0016-sensitive, 20-HETE-mediated portion of the CBF response (calculated based on the percentage decline in CBF in the presence of the cytochrome
P450 x-hydroxylase inhibitor HET0016) measured above the barrel field of the primary somatosensory cortex in response to whisker stimulation in control and IGF-1-
deficient (Igf1f/f + TBG-Cre-AAV8) mice (n = 6 in each group, *P < 0.05 vs. control; #P < 0.05 vs. control w/o HET0016; &P < 0.05 vs. Igf1f/f + TBG-Cre-AAV8 w/o
HET0016). (D–E) Production of 14,15 EET (D) and 20-HETE (E) in glutamate-activated brain slices from control and Igf1f/f + TBG-Cre-AAV8 mice as measured by liquid
chromatography/mass spectrometry (LC/MS) (n = 6 in each group; *P < 0.05 vs. control; see Methods). (F) qPCR data showing mRNA expression of cyclooxygenase-1 and
cyclooxygenase-2 (Ptgs1, Ptgs2) and EET-producing epoxygenases (Cyp2j6, Cyp2c55) in isolated astrocytes, and 20-HETE-producing x-hydroxylases (Cyp4a10, Cyp4a12,
Cyp4a14) in cortical samples of control and IGF-1-deficient mice (n = 5 in each group). *P < 0.05 vs. control. Data are mean  S.E.M. (G) Proposed mechanisms by which
age-related IGF-1 deficiency may impair neurovascular coupling responses (see Discussion). The model predicts that IGF-1 deficiency both alters astrocytic production of
eicosanoid gliotransmitters and impairs cerebromicrovascular endothelial function.
IGF-1 deficiency and neurovascular uncoupling, P. Toth et al. 1039
ª 2015 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
function and increased oxidative stress are also manifest in the peripheral
circulation in IGF-1 deficiency (Gong et al., 2014) (reviewed in Ungvari &
Csiszar (2012)). In addition to its vasodilator action, NO also confers
multifaceted endothelial protective effects, including pro-angiogenic,
anti-apoptotic, and anti-inflammatory effects (Ungvari & Csiszar, 2012;
Sonntag et al., 2013). Thus, it is likely that impaired endothelial function
associated with IGF-1 deficiency has complex phenotypic consequences
in the cerebral microcirculation (e.g., alterations in microvascular density
(Ungvari & Csiszar, 2012)), which should be elucidated by future studies.
In addition to the microvascular endothelial cells, the activation of
astrocytic production of vasodilator arachidonic acid metabolites (EETs,
prostaglandins) by neuronal-derived glutamate also has an important
role in neurovascular coupling (Petzold & Murthy, 2011). Here, we
provide the first evidence that IGF-1 deficiency alters the phenotype of
astrocytes, impairing the astrocyte-mediated portion of neurovascular
coupling. We found that IGF-1 deficiency impairs glutamate-mediated
gliovascular coupling responses (Fig. 3A), but it does not affect
glutamate release from neurons (Fig. 3C), suggesting a primary astro-
cytic deficit. Our findings indicate that the likely mechanisms by which
IGF-1 deficiency impairs glutamate-mediated gliovascular coupling
responses include decreased expression of astrocytic glutamate receptors
(Fig. 3D) and dysregulation of astrocytic synthesis of eicosanoid
gliotransmitters, likely due to altered expression of cytochrome P-450
enzymes in the astrocytes (Fig. 4). On the basis of the aforementioned
findings, one would predict that restoration of circulating IGF-1 levels in
aging would positively impact astrocyte function, improving gliovascular
coupling. This hypothesis needs to be experimentally tested in future
studies. It should be noted that NO per se is likely to regulate the
metabolism of arachidonic acid by cytochrome P-450 enzymes in the
vasculature, inhibiting the production of vasoconstrictor 20-HETE. Thus,
future studies should also determine whether decreased bioavailability of
NO contributes to increased production of 20-HETE in the brains of IGF-
1-deficient mice.
In conclusion, our results add to the growing evidence that IGF-1
exerts an important cerebromicrovascular protective effect (Toth et al.,
2014b), which likely supports multiple aspects of brain health. The
findings that isolated circulating IGF1 deficiency results in functional and
phenotypic alterations in endothelial cells and astrocytes and leads to
neurovascular uncoupling have important clinical relevance for cognitive
impairment associated with both aging and genetic IGF-1 deficiency
(e.g., Laron dwarfism). Our findings, taken together with the results of
earlier studies (reviewed in Sonntag et al. (2013)), point to potential
benefits of interventions preventing age-related IGF-1 deficiency and
promoting microvascular health for the prevention of cognitive decline in
the elderly.
Experimental procedures
All procedures were approved by and followed the guidelines of the
Institutional Animal Care and Use Committee of OUHSC in accordance
with the ARRIVE guidelines.
Postdevelopmental liver-specific knockdown of Igf1 in mice
Male mice homozygous for a floxed exon 4 of the Igf1 gene (Igf1f/f) in a
C57BL/6 background were used (Toth et al., 2014b). These mice have
the entirety of exon 4 of the Igf1 gene flanked by loxP sites, which allows
for genomic excision of this exon when exposed to Cre recombinase.
Transcripts of the altered Igf1 gene yield a protein upon translation that
fails to bind the IGF receptor. Animals were housed in the Rodent Barrier
Facility at OUHSC, on a 12-h light/12-h dark cycle, and given access to
standard rodent chow (Purina Mills, Richmond, IN, USA) and water
ad libitum. To target hepatocytes, adeno-associated viruses (AAVs) were
purchased from the University of Pennsylvania Vector Core (Philadelphia,
PA, USA). At 2 months of age, approximately 1.3 9 1010 viral particles
(as assayed by genome content at the University of Pennsylvania) of
AAV8.TBG.PI.Cre.rBG or AAV8.TBG.PI.eGFP.WPRE.bGH were adminis-
tered to Igf1f/f mice to knockdown IGF-1 or as a control, respectively, as
described (Toth et al., 2014b). While AAV8 is effective at transducing
multiple tissues after i.v. delivery, including liver, the thyroxine-binding
globulin (TBG) promoter restricts the expression solely to hepatocytes, as
described (Toth et al., 2014b). Experiments were conducted 3 months
postknockdown of Igf1.
Measurement of circulating and tissue IGF-1 levels
Venous blood was collected from the submandibular veins of animals
from both groups (Medipoint, Mineola, NY, USA). Whole blood was
centrifuged at 2500 g for 20 min at 4°C to collect serum, which was
then stored at 80°C. IGF-1 levels in sera and cortical tissue samples
were measured by ELISA (R&D Systems, Minneapolis, MN, USA)
according to the manufacturer’s protocol and are reported in ng mL1
and pg mg1 tissue, respectively.
Spatial memory testing of mice in Y-maze
Three months after IGF-1 knockdown, animals were tested for spatial
working memory in the Y-maze as described (Csiszar et al., 2013). In
brief, a Y-maze apparatus, made up of three enclosed transparent
Plexiglas arms (40 cm length 9 9 cm width 9 16 cm height) with
extra-maze visual cues around the maze, was used to assess hippocam-
pal-dependent spatial recognition memory. The test consisted of two
trials separated by an intertrial interval (4 h). All mice were transported
to the behavioral testing room in their home cages at least 1 h before
testing. In the first training (acquisition) trial, mice were placed in the
maze facing the end of a pseudorandomly chosen start arm and allowed
to explore the maze for 5 min with one of the arms closed (novel arm).
Mice were returned to their home cage until the second (retrieval) trial,
during which they could explore freely all three arms of the maze. The
time spent in each arm and number of entries were measured and
analyzed from video recordings (Ethovision, Noldus Information Tech-
nology Inc., Leesburg, VA, USA). Mice were required to enter an arm
with all four paws in order for it to be counted as an entry. The results
are expressed as number of entries (entry) and time spent (dwell) in the
novel arm as % of all entries and time spent in novel and other arm
(Sarnyai et al., 2000). Entering the novel arm more frequently and for
longer periods of time indicates intact memory and novelty-seeking
behavior because of the innate tendency of mice to explore. The maze
was cleaned with 70% ethanol between the trials.
Surgical procedures
Mice in each group were anesthetized with a-chloralose (50 mg kg1,
i.p.) and urethane (750 mg kg1, i.p.), endotracheally intubated, and
ventilated (MousVent G500; Kent Scientific Co, Torrington, CT, USA).
Rectal temperature was maintained at 37°C using a thermostatic heating
pad (Kent Scientific Co). End-tidal CO2 (including dead space) was
maintained between 3.2% and 3.7% to keep blood gas values within the
physiological range (PaCO2: 36.18  1.8 mmHg, PaO2: 109.8 
3.1 mmHg). Mice were immobilized, placed on a stereotaxic frame (Leica
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Microsystems Inc, Buffalo Grove, IL, USA), the scalp and periosteum were
pulled aside and the skull was removedover the barrel cortex, and the dura
was gently removed. The cranial window was superfused with artificial
cerebrospinal fluid (ACSF, composition: NaCl 119 mM, NaHCO3 26.2 mM,
KCl 2.5 mM, NaH2PO4 1 mM, MgCl2 1.3 mM, glucose 10 mM, CaCl2
2.5 mM, pH = 7.3, 37°C). The right femoral artery was cannulated for
arterial blood pressure measurement (Living Systems Instrumentations,
Burlington, VT, USA). The blood pressure was within the physiological
range throughout the experiments (90–110 mmHg).
Cerebral blood flow responses to whisker stimulation and
pharmacological studies
To assess neurovascular coupling, a laser Doppler probe (Transonic
Systems Inc., Ithaca, NY, USA) was placed above the barrel cortex (1–
1.5 mm posterior and 3–3.5 mm lateral to bregma), and the contralat-
eral whiskers were stimulated for 1 min at 5 Hz from side to side.
Changes in CBF (n = 7–8 mic in each group) were assessed in three trials
(5- to 10-min intervals). CBF responses to whisker stimulation were
repeated in the presence of the following inhibitors administered
topically onto the brain surface of separate groups of animals: HET0016
(inhibitor of 20-hydroxyeicosatrienoic acid (20-HETE) production,
106 mol L1 for 30 min; Cayman Chemicals, Ann Arbor, MI, USA)
(Liu et al., 2008), MS-PPOH (inhibitor of EET production,
20 9 106 mol L1 for 30 min; Cayman Chemicals) (Shi et al., 2008),
L-NAME (Nx-Nitro-L-arginine methyl ester, inhibitor of nitric oxide
synthase, 104 mol L1 for 20 min; Sigma-Aldrich, St. Louis, MO,
U.S.A.), apocynin (inhibitor of NADPH oxidases, 3 9 104 mol L1 for
30 min; Cayman Chemicals), fluoroacetate sodium (inhibitor of the
tricarboxylic acid cycle predominantly in glial cells, 104 mol L1 min;
Sigma-Aldrich, St. Louis, MO, U.S.A.) (Fonnum et al., 1997; Lecrux et al.,
2012), indomethacin (cyclooxygenase inhibitor, 5 9 104 mol L1;
Sigma-Aldrich, St. Louis, MO, U.S.A.) (Kitaura et al., 2007), MPEP (6-
Methyl-2-(phenylethynyl)pyridine hydrochloride, group I metabotropic
glutamate receptors (mGluR) subtype 5 antagonist, 5 9 105 mol L1)
(Zonta et al., 2003), and the NMDA (N-methyl-D-aspartate) receptor
antagonist D-APV (D-2-Amino-5-Phosphonovaleric acid,
5 9 105 mol L1; Cayman Chemicals) (Stobart et al., 2013). In a
separate series of experiments (n = 8 in each group), CBF responses to
topical administration of L-glutamate (500 lmol L1) (Hall et al., 2014)
were determined in the absence and presence of MPEP
(5 9 105 mol L1) and D-APV (5 9 105 mol L1) (Stobart et al.,
2013). CBF responses to acetylcholine (ACh; 105 mol L1) were also
obtained to assess maximal endothelial NO-mediated responses.
Changes in CBF are expressed as percent (%) changes from baseline.
Spontaneous neuronal activity and evoked field potentials
(SEP) in the primary somatosensory cortex
The animals were surgically prepared and ventilated as described above,
and a glass-insulated tungsten microelectrode (impedance, 2–3 MΩ;
Kation Scientific, LLC, Minneapolis, MN, USA) was inserted into the left
barrel cortex (1–1.5 mm posterior and 3–3.5 mm lateral to bregma)
through the ACSF-perfused open cranial window for recording local field
potentials. An Ag/AgCl electrode inserted in the neck muscles served as
reference. After basal activity was recorded, the right whisker pad was
stimulated by a bipolar stimulating electrode placed to the ramus
infraorbitalis of the trigeminal nerve and into the masticatory muscles.
The stimulation protocol used to investigate neurovascular coupling and
somatosensory evoked field potentials consisted of 10 stimulation
presentation trials with an intertrial interval of 70 s, each delivering a
15-s train of electrical pulses (2 Hz, 0.2 mA, intensity, and 0.3ms pulse
width) after a 10-s prestimulation baseline period. The signal was
amplified with an AC/DC differential amplifier (high pass at 1 Hz, low
pass at 1 kHz) (Model 3000; A-M Systems, Inc. Carlsborg, WA, USA) and
digitalized by the PowerLab/Labchart data acquisition system (ADInstru-
ments, Colorado Springs, CO, USA) with a sampling rate of 40 kHz.
Basal activity was analyzed as distribution of wave amplitude as a
function of frequency (Park et al., 2008), and the negative amplitude in
the somatosensory evoked field potential response was considered as
the excitatory postsynaptic potential (fEPSP) (Lind et al., 2013). Analyses
were performed on the average of 10 stimulation trials.
Cerebral glutamate release to whisker stimulation
In a separate cohort of animals, we assessed changes in extracellular
glutamate signal in response to whisker stimulation. The cranial window
was superfused continuously with ACSF. The glutamate sensor is a
platinum electrode encapsulated in a biolayer containing glutamate
oxidase and protected against the interference with ascorbate, urate,
dopamine, and 5-hydroxytriptamine. Glutamate is oxidized into hydrogen
peroxide which is sensed by the electrode. In the morning of the
experiments, the working electrode (Sarissa GLU Biosensor, 25 lm tip;
Sarissa Biomedical, Coventry, UK) was calibrated according to the
manufacturer’s guidelines in vitro, and then, it was inserted 1.5 mm
caudal and 3 mm lateral from bregma into the cerebral tissue about
500 lmdeep.Glutamate null sensors (lack of any enzymes for biosensing)
were used as controls. The reference electrode (Ag/AgCl)was inserted into
the cerebral tissue elsewhere, and the auxiliary electrode (Ag/AgCl) was
placed between the scalp and the skull. The potential was set at 0.5 V vs.
Ag/AgCl. A 3-electrode potentiostat (Quadstat) with an eDAQ data
acquisition system (eDAQ Pty Ltd., Colorado Springs, CO, USA) was used
for constant potential amperometry. Following the insertion of the
electrodes, we waited about 2-3 min until a stable baseline developed.
Then, we stimulated the right whiskers for 1 min at 5 Hz, in three
consecutive trials divided by 5- to 10-min intervals. The response was
recorded in nA and converted to lM of glutamate using the calibration
curve. Basal glutamate measurements preceding the evoked glutamate
signal were included only, and amplitudes were calculated by obtaining
the maximum increase from baseline (Onifer et al., 2012).
Astrocyte isolation
Astrocytes were immunopurified from the cortex of the experimental
animals by targeting the extracellular epitope of Glast, a glutamate
transporter specifically found on astrocytes. Cortices were isolated in ice-
cold HBSS, enzymatically digested in L15 media with 0.05% trypsin for
20 min at 37°C, titurated, and filtered through 0.7-lm mesh cell
strainer. The remaining cells were pelleted, resuspended in 100 lls of
HBSS with 0.5% BSA, and incubated with anti-Glast-PE (1:10; Miltenyi
Biotech, Bergisch Gladbach, Germany) for 10 min at 4°C. Anti-PE
microbeads (Miltenyi Biotech) were then added and incubated for an
additional 10 min at 4°C. Cells were pelleted and washed three times
with PBS with 0.5% BSA before magnetic bead column purification
(Miltenyi Biotech).
Quantitative real-time RT–PCR
A quantitative real-time RT–PCR technique was used to analyze mRNA
expression of nitric oxide synthase, NADPH oxidases, NMDA receptors,
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metabotropic glutamate receptors, cyclooxygenases, epoxygenases, and
x-hydroxylases in cortical samples and isolated astrocytes from each
experimental group using a Strategen MX3000 platform, as previously
reported (Toth et al., 2013b). In brief, total RNA was isolated with a Mini
RNA Isolation Kit (Zymo Research, Orange, CA, USA) and was reverse-
transcribed using Superscript III RT (Invitrogen, Burlington, ON, Canada)
(Toth et al., 2013a,b). Amplification efficiencies were determined using
a dilution series of a standard vascular sample. Quantification was
performed using the efficiency-corrected DDCq method. The relative
quantities of the reference genes Hprt, Ywhaz, B2 m, and Actb were
determined, and a normalization factor was calculated based on the
geometric mean for internal normalization. Fidelity of the PCR was
determined by melting temperature analysis and visualization of the
product on a 2% agarose gel.
Measurement of the production of arachidonic acid
metabolites in brain slices
To determine how IGF-1 deficiency affects the synthesis of eicosanoid
gliotransmitters, horizontal hippocampal slices of 400 lm thickness
from mice in each cohort were prepared in ice-cold solution
containing (in mmol L1) sucrose 110, NaCl 60, KCl 3, NaH2PO4
1.25, NaHCO3 28, sodium ascorbate acid 0.6, glucose 5, MgCl2 7,
and CaCl2 0.5 using a HM650V vibrating microtome (Thermo
Scientific, Burlington, ON, Canada). Slices were then transferred to
a custom-made chamber which contained oxygenated artificial cere-
brospinal fluid (aCSF) of the following composition (in mM): NaCl 126,
KCl 2.5, NaH2PO4 1.25, MgCl2 2, CaCl2 2, NaHCO3 26, glucose 10,
pyruvic acid 2, and ascorbic acid 0.4. To stimulate astrocytes,
glutamate (3 9 104 mol L1) was added to the chamber. The
samples were weighed and snap-frozen for further analysis.
The samples were homogenized in ice-cold phosphate buffer (pH
6.8). Thousand units of E. coli b-glucuronidase was added to the tissue
extract to release 20-HETE from conjugation with glucuronide. After
incubation at 37°C for 2 h, the pH in the solution was adjusted to 3 by
the addition of acetic acid. [2H4]-20-HETE (10 ng) was added, and the
sample was extracted with acidified CHCl3/CH3OH (2:1) and purified by
silica solid-phase extraction. Different samples were placed into ice-cold
0.15M KCl. After homogenization, synthetic [2H11]-labeled 14,15-DHET
(5 ng) was added as internal standard. The EETs and DHETs were
extracted from the tissue homogenates with acidified CHCl3/CH3OH
(2:1) and purified by silica solid-phase extraction, separating EETs and
DHETs.
Quantification was performed by LC/MS/MS using Acquity BEH C18
columns (1.0 9 100 mm; 1.7 lm) connected to a TSQ-Quantum
Vantage triple quadrupole spectrometer (ThermoScientific) with a linear
solvent gradient that went from 70% 15 mM aqueous ammonium
acetate (pH 8.5), 30% acetonitrile to 40% 15 mM aqueous ammonium
acetate (pH 8.5), 60% acetonitrile in 6 min and at a flow of 0.18 mL/
min. For 20-HETE analysis, we utilized collision-induced fragmentation of
20-HETE at m/z 319 and the [2H4]-20-HETE internal standard at m/z 325.
The ratio of the area of the 20-HETE peak compared to the area of the
corresponding deuterated 20-HETE was used for quantification. For EET
analysis, the EETs were converted to the corresponding DHETs by
treatment with acetic acid overnight. Then, we utilized collision-induced
fragmentation of the DHETs at m/z 337 and the [2H11]–DHET internal
standards at m/z 448. Diagnostic selective product ion analysis was
performed at m/z 206 for 14,15-DHET. These same product ions were
also used for the deuterated internal standards. Quantifications were
performed using the ratio of the area of the DHET peaks compared to
the area of the corresponding deuterated DHET peaks (Capdevila et al.,
1991; Nakagawa et al., 2006).
Determination of cerebral oxidative stress
To characterize the effect of IGF-1 deficiency on cerebral oxidative stress,
the marker for peroxynitrate action, 3-nitrotyrosine (3-NT), was assessed
in homogenates of cortical samples using OxiSelect Protein Nitrotyrosine
ELISA Kits (Cell Biolabs, San Diego, CA, U.S.A.) following the manufac-
turer’s guidelines, as previously described (Toth et al., 2013b).
Statistical analysis
Statistical analysis was carried out by unpaired t-test or two-way ANOVA
for repeated measures followed by Bonferroni multiple comparison test,
as appropriate, using Prism 5.0 for Windows (Graphpad Software, La
Jolla, CA, USA). A P value <0.05 was considered statistically significant.
Data are expressed as mean  S.E.M.
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